3Muizzuddin N, Marenus KD, Maes DH. Factors defining sensitive skin and its treatment[J]. Am J Contact Dermat, 1998,9:170-175.
4Willis CM, Shaw S, de Lacharrie're O,et al. Sensitive skin: an epidemiological study[J].Br J Dermatol, 2001,145:258-263.
5Brody HJ.Relevance of cosmeceuticals to the dermatologic surgeon [J].Dermatol Surg, 2005,31:796-798.
6Nakagawa M, Kawai K.Contact allergy to kojic acid in skin care products[J].Contact Dermatitis, 1995,32( 1):9-13.
7Sato J. Desquamation and the Role of Stratum Corneum Enzymes [M]// Leyden J, Rawlings A. Skin Moisturization. New York: Marcel-Dekker Inc, 2002: 1-94.
8Elias PM, Hatano Y, Williams ML. Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms[J]. J Allergy Clin Immunol, 2008, 121(6): 1337- 1343.
9Kao JS, Fluhr JW, Man MQ, et al. Short-term glucoeorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities[J]. J Invest Dermatol, 2003, 120(3): 456-464.
10Draelos ZD.Retinoids in cosmetics[J].Cosmet Dermatol,2005,18:3-5.
